- Home
- News & Events
- In the News
In the News
ICON experts frequently author or contribute to industry trade press.
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category.
-
Streamlining bioprocesses with automation
In this article from BioPharm International, Ronan Fox, Senior Vice President, IT R&D, provides commentary on the evolving role of automation in biopharmaceutical development.
-
Human-enabled AI driving enhancements in clinical trial site selection
In this piece from Clinical Trial Vanguard, Travis Caudill, Vice President, Feasibility, Site Identification & Clinical Informatics explores the improvements in site selection that human-enabled AI is delivering.
-
Outsourcing analytical testing: AI could transform analytical labs
In this article from Drug Development & Delivery, Suzanne Jansen, Head of QC Laboratory, discusses the importance of faster data turnaround within the analytical lab to facilitate adaptive dosing decisions that will benefit all stages of clinical trials.
-
AI has the power to revolutionise drug discovery and design
In this article from the Irish Times, Gerard Quinn, VP of IT Innovation and Informatics provides insight on how artificial intelligence can support the drug development process in order to deliver new treatments to more people, faster.
-
Automation in Clinical Trials
This article will explore how clinical trials have become more complex with more moving parts, along with the requirements for technology specific automation - increasing sophistication and the strategies for adoption.
Published by Journal for Clinical Studies Volume 15 Issue 3
-
Narratives for a clinical study report: The evolution of automation and artificial intelligence
In this article (page 28), find out what the future holds for narrative production in clinical studies now that we are in the era of AI.
-
Integration of AI in imaging clinical trials
In this article from Drug Discovery World, Sophie Winandy, Executive Director of Medical Imaging, explores the benefits of AI and how it can be integrated throughout medical imaging within clinical trials.
-
AI In Clinical Research: Now And Beyond
In this piece from Forbes, Dr. Greg Licholai, Chief Medical and Chief Innovation Officer talks about recent developments, regulatory considerations, and the promising future of AI in clinical research are reshaping the landscape of drug development and patient care.
-
AI is game changer for toughest areas of drug discovery
In this piece from Forbes, Dr. Greg Licholai, Chief Medical and Chief Innovation Officer talks about how, with proper use, AI can help accelerate a new era of medical research.
-
AI poised to revolutionise drug development
AI is poised to revolutionise drug development. ICON’s Chief Medical and Innovation Officer, Greg Licholai, explores this topic in his recent column in Forbes.